ALPHA CAPITAL ANSTALT - 30 Sep 2025 SCHEDULE 13G/A Report for QUALIGEN THERAPEUTICS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE (QLGN)

Filing Manager: ALPHA CAPITAL ANSTALT
Reporting Manager: Alpha Capital Anstalt
Security: QUALIGEN THERAPEUTICS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE
Symbol: QLGN
Shares outstanding: 1,695,506 shares
Disclosed Ownership: 153,545 shares
Ownership: 9.1%
Form type: SCHEDULE 13G/A
Filing time: 12 Nov 2025, 17:17:50 UTC
Date of event: 30 Sep 2025
Next filing: 29 Jan 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Alpha Capital Anstalt	9.1%	153,545	153,545	0	/s/ Konrad Ackermann	Konrad Ackermann/Director